Morgan Stanley’s Celularity Inc CELUW Stock Holding History

Morgan Stanley’s Portfolio CELUW Stock Details CELUW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,500	Closed	-$1K	–	7718
2022 Q2	$1K	Buy	+1,500	New	+$1.48K	﹤0.01%	7664

Other funds holding CELUW

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

Morgan Stanley's CELUW Position: Q3 2022 in Review

Morgan Stanley sold out of Celularity Inc (CELUW) in Q3 2022, closing a stake of 1,500 shares — an estimated $1K sold.

Morgan Stanley first reported a position in CELUW in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 22 funds tracked by Wall St. Rank hold CELUW as of Q3 2022.

Morgan Stanley reported no remaining Celularity Inc position as of Q3 2022 after selling out during the quarter.
Morgan Stanley sold 1,500 Celularity Inc shares in Q3 2022, an estimated $1K.
Morgan Stanley first reported a position in Celularity Inc in Q2 2022 and held it in 1 quarter.
Morgan Stanley's Celularity Inc position peaked at $1K in Q2 2022.
22 funds tracked by Wall St. Rank held Celularity Inc as of Q3 2022.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.